Meanwhile, FAK and YAP1 are frequently co‐dysregulated in the CRC patient population and appear associated with disease progression, consistent with their roles in intestinal regeneration, tumor development, and disease recurrence [8, 9, 10, 38, 39]. This evidence concerns the gene YAP1 and colorectal carcinoma.